.png)
China - CFDA Announcement No. 2017/187: Announcement on Cancellation of Drug Protection Fees, Certification Fees, Import / Export Licences Fees of Narcotic and Psychotropic Drugs
Philippines - FDA Circular No. 2012-007-A: Amending FDA Circular No. 2012-007: Reduction of Turn- Around-Time for the Regulatory Review of Clinical Trials and Revised Procedure for the Application of Import License for Investigational Products.
Singapore - Marketing Authorization Procedures: Procedure for Prescription Only to OTC Switch
Taiwan - MOHW Letter No.1081102318: Implementation of GDP on Pharmaceutical Products: Cold Chain Storage and Transportation - Supporting Measures.
Contact us at info@arqon.com.